The Food and Drug Administration (FDA) has asked hospitals and pharmacies to recall batches of rosuvastatin — a drug to control cholesterol marketed as Crestor — which the agency said had been mixed with counterfeit drugs.
FDA official Chih Lan-hui (遲蘭慧) said that global biopharmaceutical company AstraZeneca received a report from a pharmacist in New Taipei City last month that its Crestor 10mg film-coated tablets might contain counterfeit drugs in similar packaging.
The company confirmed the product was fake after sending a sample abroad to be examined.
The FDA received the report from AstraZeneca on Thursday and the New Taipei District Prosecutors’ Office launched an investigation, Chih said.
Preliminary investigations showed that counterfeit drugs were mixed with batch number MV503 of Crestor, which was distributed in October last year.
National Health Insurance Administration (NHIA) data showed that more than 570,000 people are taking Crestor with about NT$2.3 billion (US$74.1 million) spent on the drug each year.
Chih said the counterfeit drug contained atorvastatin — another lipid-lowering medication — as its main ingredient, rather than rosuvastatin.
Taipei Department of Health official Wang Ming-li (王明理), director of the Food and Drug Division, yesterday said the department’s preliminary investigation at pharmacies in the city showed that another of the company’s film-coated cholesterol-lowering products might contain counterfeit drugs as well.
“We found 66 boxes of Crestor 10mg film-coated tablets with three different batch numbers and 44 boxes of 5mg film-coated tablets with one batch number” at a pharmacy that purchased the drugs from the same source as that which provided the confirmed fakes in New Taipei City, Wang said. “We collected them for testing.”
Taiwan Pharmacist Association spokesperson Shen Tsai-ying (沈采穎) said the patent on atorvastatin expired in November 2011, so the ingredients are 30 to 50 percent cheaper than rosuvastatin, so unscrupulous manufacturers of atorvastatin can captialize on the difference in cost.
Shen said many pharmacists reported that most of the MV503 batch has already been sold.
If people have medication from that batch, they should not take it, but should exchange it for the same drug from a different batch, Shen said.
Eight restaurants in Taiwan yesterday secured a one-star rating from the Michelin Guide Taiwan for the first time, while three one-star restaurants from last year’s edition were promoted to two stars. Forty-three restaurants were awarded one star this year, including 34 in Taipei, five in Taichung and four in Kaohsiung. Hosu (好嶼), Chuan Ya (川雅), Sushi Kajin (鮨嘉仁), aMaze (心宴), La Vie by Thomas Buhner, Yuan Yi (元一) and Frassi in Taipei and Front House (方蒔) in Kaohsiung received a one-star rating for the first time. Hosu is known for innovative Taiwanese dishes, while Chuan Ya serves Sichuan cuisine and aMaze specializes
STATS: Taiwan’s average life expectancy of 80.77 years was lower than that of Japan, Singapore and South Korea, but higher than in China, Malaysia and Indonesia Taiwan’s average life expectancy last year increased to 80.77 years, but was still not back to its pre-COVID-19 pandemic peak of 81.32 years in 2020, the Ministry of the Interior said yesterday. The average life expectancy last year increased the 0.54 years from 2023, the ministry said in a statement. For men and women, the average life expectancy last year was 77.42 years and 84.30 years respectively, up 0.48 years and 0.56 years from the previous year. Taiwan’s average life expectancy peaked at 81.32 years in 2020, as the nation was relatively unaffected by the pandemic that year. The metric
Taiwan High Speed Rail Corp. (THSRC) plans to ease strained capacity during peak hours by introducing new fare rules restricting passengers traveling without reserved seats in 2026, company Chairman Shih Che (史哲) said Wednesday. THSRC needs to tackle its capacity issue because there have been several occasions where passengers holding tickets with reserved seats did not make it onto their train in stations packed with individuals traveling without a reserved seat, Shih told reporters in a joint interview in Taipei. Non-reserved seats allow travelers maximum flexibility, but it has led to issues relating to quality of service and safety concerns, especially during
A magnitude 5.1 earthquake struck Chiayi County at 4:37pm today, the Central Weather Administration (CWA) said. The hypocenter was 36.3km southeast of Chiayi County Hall at a depth of 10.4km, CWA data showed. There were no immediate reports of damage resulting from the quake. The intensity of the quake, which gauges the actual effect of a seismic event, measured 4 in Chiayi County, Tainan and Kaohsiung on Taiwan's seven-tier intensity scale, the data showed. The quake had an intensity of 3 in Chiayi City and Yunlin County, while it was measured as 2 in Pingtung, Taitung, Hualien, Changhua, Nantou and Penghu counties, the data
RSS